QuikLinx Products Advice & Info Purchasing Contact Us

 

The Dräger DrugTest® System is an onsite immunoassay test for the qualitative detection of amphetamines,
designer amphetamines, cocaine metabolites, opiates and cannabinoids in oral fluid samples. 

The first opto-electronic analyser available for portable and onsite use, it allows instant test results
to be obtained without by companies' in-house personnel without the need for any specialised training,
eliminating very costly medically-supervised testing for most routine testing operations.

 

Easy and reliable
The system consists of two main components: the Dräger DrugTest® Kit for Oral Fluids and the Dräger DrugTest® Analyzer (test evaluation reader and data management system).

The Analyzer is used for the determination of the analytes detected by the Dräger DrugTest® Kit in the oral fluid samples. The system is designed both for mobile use at control points ("Point-of-Collection-Test") and for stationary use. The novel technique requires a special opto-electronic device-supported excitation and analysis. This requirement is met by the Dräger DrugTest® Analyzer, which is easy-to-operate, intuitive and menu-driven via the device’s display screen. The Analyzer comes with comprehensive operating instructions including technical specification, source references, trouble-shooting and other useful system information.

On-Screen Results
The unambiguous measurement results are shown in an easy-to-read form on the illuminated display. This rules out the subjective evaluation of the results influenced by the user or environmental factors such as lighting conditions. The Dräger DrugTest® system facilitates fast, reliable and easy drug detection.

Hygienic
The samplers are individually and hygienically packaged and clip into place automatically, ensuring hygienic and drip-free disposal of the test kit components.

Highly Sensitive
Within just ten minutes, illegal substances (cocaine, opiates, amphetamines, methamphetamines, phencyclidine and cannabinoids) can be reliably detected using the test strip before they revert to their respective metabolites. Immunochemical detection of Δ9 tetrahydrocannabinol (Δ9 THC) – the psychoactive component in marijuana, hashish and hashish oil – reacts with a particularly high level of sensitivity.

Onsite Analysis & Confirmations
As well as achieving very high sensitivity, the test offers the user many other advantages. The Dräger Drugtest ensures that samples are analysed directly on site for immediate results.

Mobile and Printing Options
If required the standard the unit can be connected wirelessly with the optional thermal printing unit.  Also available are a purpose-designed mobile Carry Case and keyboard (for subject data entry prior to hard-copy printout)

Confirmatory Dual-Sample Lab Tests
Should a confirmation lab test be required subsequent to a positive Oral DrugCheck test, we would recommend the use of the
Dräeger DCD5000 sample collection kit.  This is still salvia based (thereby avoiding all the difficulties of Urine Sampling) but provides the dual-sample controls and full chain of custody reporting required for lab confirmations. The DCD5000 kits are packed in 20's and are available to special order only.

TECHNICAL DATA
limit value concentrations (cut-off values)

  Drug ng/ml
COC Cocaine 20
OPI Opiate 40
AMP Amphetamine 50
MET Methamphetamine 50
PCP Phencyclidine 10
THC Tetrahydrocannabinol 50

Draeger DrugTest Analyser
£ exc VAT

Buy Now

Download Brochure